Furthermore, a multiantigen vaccine targeting Neu, IGFBP-2 and IGF1R was highly effective at preventing tumor progression in mice with preinvasive breast disease, whereas an individual vaccine was partially effective [45]. This evidence concerns the gene IGFBP2 and breast disorder.